| View |
|
DRP-14019-03
|
Co - Amoxiclav
|
Orapen S
|
457 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillins)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
13 March 2024
|
06 June 2028
|
| View |
|
DRP-14052-01
|
Ketoanalogues and Essential Amino Acids
|
Analou
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
08 June 2028
|
| View |
DRP-14067-01_PI_01.pdf
|
DRP-14067-01
|
Levothyroxine Sodium
|
Thyroxil
|
100 mcg
|
Tablet
|
Thyroid Hormone
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
09 June 2028
|
| View |
|
DRP-14088-05
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
None
|
3 mg/1 mg (0.3%/0.1% w/v) per mL
|
Sterile Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
20 June 2028
|
| View |
|
DRP-14091-02
|
Metformin Hydrochloride
|
Diamet
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose - Lowering Drug (Biguanide)
|
Mercury Laboratories Ltd.
|
India
|
CLIDP Conversion
|
04 April 2024
|
20 June 2028
|
| View |
|
DRP-14110-01
|
Capecitabine
|
Capeget
|
500 mg
|
Film-Coated Tablet
|
Antimetabolite (Pyrimidine analogue )
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
22 June 2028
|
| View |
|
DRP-14170-02
|
Enzalutamide
|
Enzagen
|
40 mg
|
Capsule
|
Androgen Receptor Antagonist
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
22 March 2024
|
01 August 2028
|
| View |
|
DRP-14203-01
|
Clindamycin (as phosphate)
|
Dalasave
|
150 mg/mL (300 mg / 2mL)
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Maxitech Pharma (Pvt.) Ltd
|
Pakistan
|
CLIDP Conversion
|
28 March 2024
|
20 July 2028
|
| View |
|
DRP-14215-01
|
Iron (as Iron Sucrose)
|
Ironsave
|
20 mg/mL
|
Solution for injection (IV)
|
Anti-anemic Preparation
|
Maxitech Pharma (Pvt) Ltd.
|
Pakistan
|
CLIDP Conversion
|
17 March 2024
|
27 July 2028
|
| View |
|
DRP-14375-03
|
Dutasteride + Tamsulosin Hydrochloride
|
Dutam
|
500 mcg/400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-adrenoreceptor Antagonist)
|
Pell Tech Healthcare Private Ltd.
|
India
|
CLIDP Conversion
|
25 March 2024
|
31 August 2028
|
| View |
|
DRP-14435
|
Co-Amoxiclav
|
Bactoclav
|
500 mg/125 mg
|
Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
21 March 2024
|
25 January 2029
|
| View |
|
DRP-14484-03
|
Potassium citrate
|
Calta
|
1.620 g (15 mEq)
|
Extended-Release Tablet
|
Antiurolithic
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
12 September 2028
|
| View |
|
DRP-14606-01
|
Apixaban
|
Urania
|
5 mg
|
Film-Coated Tablet
|
Anti-Thrombotic Agent (Direct Factor Xa Inhibitor)
|
Baroque Pharmaceuticals Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 March 2024
|
27 October 2028
|
| View |
|
DRP-14610-01
|
Azithromycin (as dihydrate)
|
None
|
200 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
07 April 2027
|
| View |
|
DRP-14620-01
|
Dabigatran Etexilate (as mesylate)
|
Karisa
|
150 mg
|
Capsule
|
Antithrombotic Agent (Direct Thrombin Inhibitor)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
17 March 2024
|
14 November 2028
|
| View |
|
DRP-14621-01
|
Dabigatran Etexilate (as mesylate)
|
Karisa
|
110 mg
|
Capsule
|
Antithrombotic Agent (Direct Thrombin Inhibitor)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
14 November 2028
|
| View |
|
DRP-14622-01
|
Dabigatran Etexilate (as mesylate)
|
Karisa
|
75 mg
|
Capsule
|
Antithrombotic Agent (Direct Thrombin Inhibitor)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 March 2024
|
14 November 2028
|
| View |
|
DRP-14634-01
|
Clarithromycin
|
Claritone
|
50 mg/mL (250 mg/5 mL)
|
Powder for Oral Suspension (Raspberry Flavor)
|
Antibacterial (Macrolide)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
10 March 2024
|
08 November 2028
|
| View |
|
DRP-14734-01
|
Sertraline
|
Sertrakip
|
50 mg
|
Tablet
|
Antidepressant
|
Micro Labs Limited
|
India
|
CLIDP Conversion
|
09 March 2024
|
10 June 2028
|
| View |
|
DRP-14738-01
|
Quetiapine (as fumarate)
|
Quetigrand 200
|
200 mg
|
Film-Coated Tablet
|
Antipsychotic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
28 March 2024
|
20 December 2028
|